Seroconversion against SARS-CoV-2 occurred after the recovery in patients with COVID-19

J Med Virol. 2021 Feb;93(2):692-694. doi: 10.1002/jmv.26495. Epub 2020 Sep 29.

Authors

Shinya Yamamoto¹, Makoto Saito¹, Etsuko Nagai¹, Keiko Toriuchi¹, Hiroyuki Nagai¹, Hiroshi Yotsuyanagi¹, Yu Nakagama², Yasutoshi Kido², Eisuke Adachi¹

Affiliations

¹ Department of Infectious Diseases and Applied Immunology, Institute of Medical Science, The University of Tokyo, Tokyo, Japan.
² Department of Parasitology, Graduate Scholl of Medicine, Osaka City University, Osaka, Japan.

PMID: 32897566
DOI: 10.1002/jmv.26495

No abstract available

Publication types

Letter

MeSH terms

Adult
Aged
Antibodies, Viral / blood*
COVID-19 / immunology*
Convalescence*
Female
Humans
Immunoglobulin G / blood
Immunoglobulin M / blood
Longitudinal Studies
Male
Middle Aged
Retrospective Studies
SARS-CoV-2 / immunology
Seroconversion*

Substances

Antibodies, Viral
Immunoglobulin G
Immunoglobulin M